Quick Facts

FONT-SIZE

Plus

Neg

SHARE

mail

E-MAIL

GEA Group Expects Sale Growth Of At Least 5% For FY12 - Quick Facts

RELATED NEWS

GEA Group Q1 Pretax Profit Rises - Quick Facts

GEA Group Reports Q1 Order Intake Of EUR1.45 Bln;sees FY Moderate Revenue Growth

GEA Group Continues To Expect Higher EBITDA In FY13; Sees Growth In FY14

GEA Group Annual EPS Down - Quick Facts

GEA Group Extends CEO's Employment Till December 2016 - Quick Facts

6/28/2012 11:44 AM ET

GEA Group (GEAGY.PK,GEAGF.PK) on Thursday said it expects an order intake growth of at least 5%, sale growth of at least 5% for fiscal 2012. The company expects fiscal 2012 capital expenditure of up to 3.0% of sales due to special projects in particular within GEA ME.

Click here to receive FREE breaking news email alerts for GEA Group AG and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Quick Facts

<<Previous 39 Articles

Editors Pick

HP Profit Falls Yet Tops Estimates

Hewlett-Packard Co. said Wednesday after the markets closed that its second quarter profit fell 32% from last year, hurt by lower revenue and weaker margins amid a slump in PC sales. However, the company's quarterly earnings per share, excluding items, came in above analysts' expectations, but its quarterly revenue fell short of analysts' forecast.

Worries About Fed Tapering Lead To Sell-Off On Wall Street - U.S. Commentary

Stocks showed a substantial downturn over the course of the trading day on Wednesday after seeing some strength in morning trading. Renewed worries about the Federal Reserve tapering its asset purchase program contributed to the sharp pullback by the markets. The major averages climbed off their worst levels going into the close but still ended the day firmly negative.

Fed Minutes Show Some Members Want To Scale Back QE3 This Summer

Some members of the Federal Reserve favor scaling back the central bank's $85 billion a month asset purchase program this summer as long as the economy continues to improve, according the the minutes of the Fed's April 30-May 1 meeting. "A number of participants expressed willingness to adjust the...

FREE Newsletters & Alerts

Breaking News Alerts

Daily Market Briefing

Health

Technology

Biotechnology

signup

Follow RTT

Most Read
Most E-Mailed

FDA Clears Oramed Pharma's IND For ORMD-0801 - Quick Facts

Plains Exploration Declars Special Dividend - Quick Facts

Covidien Nellcor Pulse Oximetry Portfolio Gets 510(k) Clearance For Motion Claim

Genesys To Buy SoundBite Communications For $5.00 Per Share

Dolphin Capital Announces Sale Of Venus Rock Golf Resort Interest

G4S Plc Names Ashley Almanza CEO; Eddie Aston Named New COO

Pre-market Movers For May 20 (YHOO, WCRX, ACT, WBSN, CHK, PXP, XNPT, PPHM)

Novartis Says BOLERO-3 Study On Afinitor Meets Main Goal

GE Capital To Pay $6.5 Bln In Dividends To GE In 2013, Plans Special Dividend

Goodman Networks, Multiband To Merge In $116 Mln Cash Deal - Quick Facts

FDA Clears Oramed Pharma's IND For ORMD-0801 - Quick Facts

Invensys To Return About GBP 625 Mln Cash To Shareholders - Quick Facts

EveryWare Global, ROI Acquisition Complete Business Combination

Covidien Nellcor Pulse Oximetry Portfolio Gets 510(k) Clearance For Motion Claim

GE Capital To Pay $6.5 Bln In Dividends To GE In 2013, Plans Special Dividend

Ensco Shareholders Elect 2 Directors, Pass $2 Bln Share Repurchase Authorization

AIG To Invest $92.5 Mln In Rights Offering By China's PICC

G4S Plc Names Ashley Almanza CEO; Eddie Aston Named New COO

Zytronic H1 Pretax Profit Decreases - Quick Facts

Biogen Idec Submits BLA To FDA For Approval Of Plegridy In Multiple Sclerosis

FREE Newsletters, Analysis & Alerts

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.

Email Address